Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Investigating the Probable Potential of Dihydropyridine Calcium Channel Blockers: Drug Repositioning in Cancer Publisher



Kazemabad MJE1 ; Dadkhah PA2 ; Amani H3 ; Toni SA4 ; Alamshiry MYI4 ; Shahrokhi M5 ; Tizro N6 ; Khani S7
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, School of Medicine, Qom University of Medical Sciences, Qom, Iran
  2. 2. Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  4. 4. Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  5. 5. School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
  6. 6. Student Research Committee, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
  7. 7. Neuroscience Research Center, Qom University of Medical Sciences, Qom, Iran

Source: Current Cancer Therapy Reviews Published:2024


Abstract

In contemporary medicine, cancers are recognized as significant concerns warranting attention. Over time, scientific advancements have assisted physicians worldwide in exploring novel approaches. Among these potential solutions are calcium channel blockers (CCBs), which hold considerable importance and find extensive application across various medical conditions. CCBs, classified as dihydropyridines and non-dihydropyridines, have been widely utilized in the management of diverse cancer types. Given the diverse facets of dihydropyridine CCBs, our objective was to comprehensively gather and summarize pertinent data regarding the impact of this medication class on different cancer types. © 2024 Bentham Science Publishers.